Fennec Pharmaceuticals (FENC) Interest & Investment Income (2010 - 2026)

Fennec Pharmaceuticals (FENC) has 16 years of Interest & Investment Income data on file, last reported at $228000.0 in Q4 2025.

• Quarterly Interest & Investment Income fell 42.86% year-over-year to $228000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $787000.0 (down 53.21% YoY) and the FY2025 annual result came in at $787000.0, down 53.21% from the prior year.
• Interest & Investment Income improved to $228000.0 in Q4 2025, from $152000.0 in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $570000.0 in Q2 2024 to a low of $9000.0 in Q1 2022.
• A 5-year average of $157950.0 and a median of $115000.0 in 2023 frame the typical range for Interest & Investment Income.
• Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 1177.78% — and 2025, when it plunged 70.54%.
• Tracing FENC's Interest & Investment Income over 5 years: stood at $13000.0 in 2021, then soared by 1076.92% to $153000.0 in 2022, then decreased by 24.84% to $115000.0 in 2023, then surged by 246.96% to $399000.0 in 2024, then plunged by 42.86% to $228000.0 in 2025.
• The last three Interest & Investment Income figures came in at $228000.0 (Q4 2025), $152000.0 (Q3 2025), and $171000.0 (Q2 2025), per Business Quant data.